Crossref
New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia
Clinical Schizophrenia & Related Psychoses · 2012-10 · 6 (3) · 122-133
DOI: 10.3371/csrp.6.3.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Schizophrenia & Related Psychoses, 2012-10. Verfasst von Nobumi Miyake und 2 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Miyake, N., Miyamoto, S., & Jarskog, L. F. (2012). New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia. Clinical Schizophrenia & Related Psychoses, 6(3), 122-133. https://doi.org/10.3371/csrp.6.3.4
Vancouver
Miyake N, Miyamoto S, Jarskog LF. New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia. Clinical Schizophrenia & Related Psychoses. 2012;6(3):122-133. doi:10.3371/csrp.6.3.4
BibTeX
@article{Miyake2012,
author = {Miyake, Nobumi and Miyamoto, Seiya and Jarskog, L. Fredrik},
title = {New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia},
journal = {Clinical Schizophrenia & Related Psychoses},
year = {2012},
volume = {6},
number = {3},
pages = {122--133},
doi = {10.3371/csrp.6.3.4}
}
EUVIMED